1. Home
  2. IART vs EVO Comparison

IART vs EVO Comparison

Compare IART & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IART
  • EVO
  • Stock Information
  • Founded
  • IART 1989
  • EVO 1993
  • Country
  • IART United States
  • EVO Germany
  • Employees
  • IART N/A
  • EVO N/A
  • Industry
  • IART Medical/Dental Instruments
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • IART Health Care
  • EVO Health Care
  • Exchange
  • IART Nasdaq
  • EVO Nasdaq
  • Market Cap
  • IART 1.7B
  • EVO 1.5B
  • IPO Year
  • IART 1995
  • EVO 2021
  • Fundamental
  • Price
  • IART $24.10
  • EVO $4.11
  • Analyst Decision
  • IART Sell
  • EVO Buy
  • Analyst Count
  • IART 7
  • EVO 2
  • Target Price
  • IART $24.67
  • EVO $5.90
  • AVG Volume (30 Days)
  • IART 555.0K
  • EVO 184.0K
  • Earning Date
  • IART 02-26-2025
  • EVO 11-06-2024
  • Dividend Yield
  • IART N/A
  • EVO N/A
  • EPS Growth
  • IART N/A
  • EVO N/A
  • EPS
  • IART N/A
  • EVO N/A
  • Revenue
  • IART $1,564,920,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • IART $6.71
  • EVO $3.89
  • Revenue Next Year
  • IART $6.20
  • EVO $9.65
  • P/E Ratio
  • IART N/A
  • EVO N/A
  • Revenue Growth
  • IART 1.45
  • EVO N/A
  • 52 Week Low
  • IART $16.81
  • EVO $2.85
  • 52 Week High
  • IART $45.42
  • EVO $8.39
  • Technical
  • Relative Strength Index (RSI)
  • IART 61.11
  • EVO 42.87
  • Support Level
  • IART $21.26
  • EVO $4.00
  • Resistance Level
  • IART $22.52
  • EVO $4.63
  • Average True Range (ATR)
  • IART 0.92
  • EVO 0.14
  • MACD
  • IART 0.16
  • EVO -0.04
  • Stochastic Oscillator
  • IART 93.73
  • EVO 16.88

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: